Introduction
============

Septic shock is characterized by severe vasodilation and hypotension refractory to aggressive fluid resuscitation \[[@B1]\]. Despite the normalization of cardiac output, evidence of tissue hypoperfusion is frequently present. Accordingly, organ dysfunctions usually develop despite normal or increased oxygen transport (DO~2~). Microcirculatory alterations could be an underlying explanation for these findings \[[@B2]\]. Experimental models of resuscitated septic shock show that microvascular perfusion is altered despite the normalization of systemic and regional hemodynamics \[[@B3]\]. In addition, septic patients systematically exhibit severe disorders in sublingual microcirculation that are strongly associated with organ failures and outcome \[[@B4],[@B5]\]. The ability to improve sublingual microcirculation has also been related to survival \[[@B5]\]. Moreover, sublingual perfusion might be enhanced by different therapeutic strategies that include the use of vasoactive drugs \[[@B6],[@B7]\]. In this way, improving microcirculation might be an important goal in the resuscitation of patients with septic shock.

An approach to improve microcirculation is to increase the perfusion pressure. When the mean arterial pressure (MAP) decreases below an autoregulatory threshold of about 60 to 65 mmHg, organ perfusion becomes pressure dependent \[[@B8]\]. Nevertheless, intravascular thrombosis and vasoconstrictor mediators, along with regional deficiencies in nitric oxide production, could alter vascular reactivity and shift the autoregulatory threshold to higher values \[[@B9],[@B10]\]. Consequently, the increase in MAP could improve tissue perfusion. Clinical studies, however, have shown that the elevation in MAP beyond 65 mmHg fails to increase systemic oxygen metabolism, skin microcirculatory blood flow, urine output, splanchnic perfusion, or renal function \[[@B11],[@B12]\]. The experimental evidence regarding this issue, however, is controversial \[[@B13]-[@B17]\].

Our goal was to assess the effects of titration of a norepinephrine infusion to increasing levels of MAP on sublingual microcirculation. We hypothesized that the increase in MAP from 65 to 75 mmHg, and then to 85 mmHg does not improve sublingual microcirculatory blood flow. At the time of submission of this manuscript, a very similar study was published \[[@B18]\], which reported that escalating doses of norepinephrine in septic patients increased DO~2~and tissue oxygenation, and were not associated with significant changes in preexisting sublingual microvascular alterations. The results of our study confirm these previous findings, but suggest that the individual responses are related to the basal microcirculatory condition.

Materials and methods
=====================

The protocol was approved by the Institutional Review Boards of Sanatorio Otamendi and Clínica Bazterrica. Informed consent was obtained from the next of kin of all patients admitted to the study.

Setting
-------

This study was conducted in two teaching intensive care units.

Patients
--------

The study population included 20 septic shock patients \[[@B19]\] requiring norepinephrine despite adequate fluid resuscitation to maintain a MAP of 65 mmHg or higher (Table [1](#T1){ref-type="table"}). They were mechanically ventilated in controlled mode and received infusions of midazolam and fentanyl. All patients had a systemic arterial catheter and a pulmonary artery catheter inserted. A tonometric nasogastric tube was placed into the stomach (TRIP NGS Catheter, Tonometrics, Worcester, MA, USA), after which radiographic confirmation of catheter position was obtained. All patients received intravenous ranitidine. The clinical characteristics of the patients are presented in Table [1](#T1){ref-type="table"}.

###### 

Clinical and epidemiological characteristics of the patients

  -------------------------------------------------- -------------
  **Age, years**                                     72 ± 12
  **Gender, % male**                                 55
  **SOFA score**                                     9.8 ± 2.8
  **APACHE II score**                                24.4 ± 5.4
  **APACHE II predicted risk mortality**             50.8 ± 17.5
  **Actual mortality, %**                            50
  **Source of sepsis, n (%)**                        
   **Pneumonia**                                     9 (45)
   **Intra-abdominal infection**                     3 (15)
   **Primary bacteremia**                            3 (15)
   **Endovascular infection**                        2 (10)
   **Cellulitis**                                    2 (10)
   **Urinary tract infection**                       1 (5)
  **Fluid balance on the previous day, ml**          4592 ± 3156
  **Fluid administration on the previous day, ml**   6183 ± 2601
  -------------------------------------------------- -------------

APACHE = Acute Physiology and Chronic Health Evaluation; SOFA = Sepsis-related Organ Failure Assessment.

Measurements and derived calculations
-------------------------------------

Serial measurements of heart rate, MAP, mean arterial pulmonary pressure, pulmonary artery occlusion pressure, and central venous pressure were performed. Transducers were referenced to the midaxillary line and all pressures were taken at end-expiration. Cardiac output was measured by thermodilution using three injections of saline solution (10 cc) at room temperature.

Arterial, mixed venous, and central venous blood samples were analyzed for gases, hemoglobin, and oxygen saturation (AVL OMNI 9, Roche Diagnostics, Graz, Austria). Sodium (Na), potassium (K) and chloride (Cl) ions (selective electrode ion, AEROSET, Abbott Laboratories, Abbott Park, IL, USA), albumin (Bromcresol-sulfonphthaleinyl), and lactate (selective electrode ion, AVL OMNI 9) were measured in arterial blood samples. The albumin-corrected anion gap was calculated \[[@B20]\] as:

Derived hemodynamic and DO~2~variables were calculated according to standard formulae.

Intramucosal partial pressure of carbon dioxide (PCO~2~) was measured with a tonometer using an automated air tonometry system (Tonocap; Datex Ohmeda, Helsinki, Finland). Its value was used to calculate the intramucosal-arterial PCO~2~difference (ΔPCO~2~).

Microvideoscopic measurements and analysis
------------------------------------------

The microcirculatory network was evaluated in the sublingual mucosa using a sidestream dark field (SDF) imaging device (Microscan^®^, MicroVision Medical, Amsterdam, Netherlands) \[[@B21]\].

Different cautions and steps were followed to obtain images of adequate quality and to ensure good reproducibility. Video acquisition and image analyses were performed by well-trained researchers (AD, MOP and VSKE). After gentle removal of saliva by isotonic-saline-drenched gauze, steady images of at least 20 seconds were obtained while avoiding pressure artifacts using a portable computer and an analog/digital video converter (ADVC110, Canopus Co, San Jose, CA, USA). Video clips were stored as AVI files to allow computerized frame-by-frame image analysis. SDF images were acquired from at least five different sites. Adequate focus and contrast adjustment were verified, and images of poor quality were discarded. The entire sequence was used to characterize the semi-quantitative characteristics of microvascular blood flow, particularly the presence of stopped or intermittent flow.

Video clips were analyzed blindly and randomly using different approaches. First, we used a previously validated semi-quantitative score \[[@B22]\]. It distinguishes between no flow (0), intermittent flow (1), sluggish flow (2), and continuous flow (3) \[[@B22]\]. A value was assigned to each individual vessel. The overall score, called the microvascular flow index (MFI), is the average of the individual values. For each patient, the values from five to eight videos were averaged. In addition, vascular density was quantified as the number of vessels per mm^2^. To determine heterogeneity of perfusion in each territory, the flow heterogeneity index was calculated as the highest MFI minus the lowest MFI divided by the mean MFI \[[@B23]\]. These quantifications of flow were made per group of vessel diameter: small (capillaries), 10 to 20 μm; medium, 21 to 50 μm; and large, 51 to 100 μm. Finally, the percentage of perfused vessels and the total and capillary perfused vascular densities were calculated \[[@B4],[@B24]\]. The percentage of perfused vessels was calculated as the number of vessels with flow 2 and 3 divided by the total number of vessels multiplied by 100.

Study protocol
--------------

After fluid resuscitation failed to improve MAP, a norepinephrine infusion was adjusted to reach a MAP of 65 mmHg in all patients. After a period of at least two hours in which the requirement of norepinephrine to maintain a MAP of 65 mmHg remained unchanged, the measurements were performed. Norepinephrine was then titrated to reach a MAP of 75 mmHg. After 30 minutes at this MAP, new measurements were taken. Finally, norepinephrine infusion was increased to achieve a MAP of 85 mmHg and, after 30 minutes at this MAP, a final set of measurements were taken.

No additional sedation, antipyretics or vasoactive drugs were administered during the study period. The infusions of midazolam and fentanyl were kept constant at rates of 0.99 ± 0.22 mg/kg/hour and 0.82 ± 0.20 μg/kg/hour, respectively.

Analysis of data
----------------

After showing a normal distribution, data were analyzed using repeated measurements analysis of variance (ANOVA) and Dunnett test. Linear trends between the different variables and increasing levels of MAP were calculated \[[@B25]\]. A *P*\< 0.05 was considered significant. Data are showing as mean ± standard deviation.

Results
=======

Effects on hemodynamic and oxygen transport variables
-----------------------------------------------------

Increasing doses of norepinephrine induced the target values of MAP. Cardiac index and pulmonary pressures increased as norepinephrine infusion was augmented. Heart rate, DO~2~and oxygen consumption remained unchanged (Table [2](#T2){ref-type="table"}).

###### 

Changes in hemodynamic, oxygen transport, and tonometric variables as mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine

                                                   **Mean arterial blood pressure**   **ANOVA**       **Linear trend**               
  ------------------------------------------------ ---------------------------------- --------------- ------------------ ----------- -----------
  **Norepinephrine doses (μg/kg/min)**             0.48 ± 0.43                        0.65 ± 0.68\*   0.74 ± 0.67\*      \< 0.0001   \< 0.0001
  **Heart rate (beats/min)**                       94 ± 21                            92 ± 18         93 ± 18            0.59        0.43
  **Mean arterial blood pressure (mmHg)**          65 ± 2                             76 ± 2\*        85 ± 2\*           \< 0.0001   \< 0.0001
  **Mean pulmonary artery pressure (mmHg)**        28 ± 7                             30 ± 7\*        30 ± 7\*           \< 0.0001   \< 0.0001
  **Pulmonary artery occlusion pressure (mmHg)**   14 ± 4                             15 ± 4          16 ± 4             0.06        0.02
  **Central venous pressure (mmHg)**               11 ± 4                             12 ± 4          12 ± 4             0.18        0.47
  **Cardiac index (l/min/m^2^)**                   2.98 ± 0.99                        3.11 ± 1.07     3.23 ± 1.02\*      0.0002      \< 0.0001
  **Oxygen transport (ml/min/m^2^)**               366 ± 137                          379 ± 145       383 ± 166          0.53        0.28
  **Oxygen consumption (ml/min/m^2^)**             100 ± 33                           91 ± 31         90 ± 40            0.61        0.63
  **Intramucosal-arterial pCO~2~(mmHg)**           15 ± 15                            16 ± 18\*       16 ± 18            0.03        0.06

\* *P*\< 0.05 vs. basal (Dunnett post hoc test after repeated measures ANOVA).

ANOVA = analysis of variance; pCO~2~= partial pressure of carbon dioxide.

Effects on lactate and acid-base parameters
-------------------------------------------

Arterial lactate levels were stable. Venous oxygen saturations and pressures increased while other acid-base variables were unmodified (Table [3](#T3){ref-type="table"}).

###### 

Changes in arterial lactate, hemoglobin, blood gases and oxygen saturations as mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine

                                         **Mean arterial blood pressure**   **ANOVA**       **Linear trend**          
  -------------------------------------- ---------------------------------- --------------- ------------------ ------ -------
  **Arterial lactate (mmol/L)**          2.6 ± 2.8                          2.4 ± 2.7       2.5 ± 2.7          0.27   0.32
  **Hemoglobin (g%)**                    9.6 ± 2.3                          9.6 ± 2.4       9.6 ± 2.3          0.76   0.79
  **Arterial pH**                        7.26 ± 0.11                        7.26 ± 0.11     7.26 ± 0.11        0.44   0.29
  **Arterial PCO~2~(mmHg)**              39 ± 10                            39 ± 10         40 ± 11            0.73   0.57
  **Arterial PO~2~(mmHg)**               112 ± 48                           113 ± 45        108 ± 34           0.39   0.25
  **Arterial HCO~3~^-^(mmol/l)**         18 ± 5                             18 ± 5          18 ± 5             0.50   0.43
  **Arterial oxygen saturation**         0.96 ± 0.02                        0.96 ± 0.02     0.96 ± 0.03        0.67   0.44
  **Mixed venous pH**                    7.23 ± 0.11                        7.24 ± 0.10     7.24 ± 0.10        0.78   0.49
  **Mixed venous PCO~2~(mmHg)**          45 ± 11                            45 ± 11         45 ± 11            0.90   0.69
  **Mixed venous PO~2~(mmHg)**           42 ± 7                             43 ± 7          44 ± 8\*           0.04   0.02
  **Mixed venous HCO~3~^-^(mmol/l)**     19 ± 5                             19 ± 5          19 ± 5             0.18   0.08
  **Mixed venous oxygen saturation**     0.70 ± 0.08                        0.72 ± 0.08\*   0.73 ± 0.07\*      0.01   0.005
  **Central venous oxygen saturation**   0.74 ± 0.08                        0.76 ± 0.08\*   0.77 ± 0.08\*      0.01   0.004
  **Arterial anion gap (mmol/L)**        18 ± 6                             19 ± 6          20 ± 7             0.16   0.06

\* *P*\< 0.05 vs. basal (Dunnett *post hoc*test after repeated measures ANOVA).

ANOVA = analysis of variance; HCO~3~= bicarbonate; pCO~2~= partial pressure of carbon dioxide; pO~2~= partial pressure of oxygen.

Effects on gastric tonometry
----------------------------

ΔPCO~2~did not change throughout the study (Table [2](#T2){ref-type="table"}).

Effects on sublingual microcirculation
--------------------------------------

Although the total vascular density was not significantly altered, there was a trend to a decreased capillary density (ANOVA *P*= 0.09, linear trend *P*= 0.03; Table [4](#T4){ref-type="table"}). The MFI and the percentage of perfused vessels were unchanged in the different types of vessels at increasing MAP values. The total perfused vascular density was unmodified for MAP values of 65, 75, and 85 mmHg (38 ± 14, 37 ± 15, 37 ± 4 vessels/mm^2^, respectively, ANOVA *P*= 0.94, linear trend *P*= 0.76); however, there was a trend to a decreased perfused capillary density (18 ± 10, 17 ± 10, 14 ± 2 vessels/mm^2^, respectively, ANOVA *P*= 0.09, linear trend *P*= 0.045). The heterogeneity flow index also remained unchanged (Table [4](#T4){ref-type="table"}). The individual behaviour of capillary density, capillary MFI, percentage of perfused capillaries, perfused capillary density and capillary heterogeneity flow index are depicted in Figures [1](#F1){ref-type="fig"} to [5](#F5){ref-type="fig"}. There was, however, considerable interindividual variability. In particular, there was a strong linear relationship between the changes of perfused capillary density, when MAP was increased from baseline to 85 mmHg, with the basal perfused capillary density at a MAP of 65 mmHg (Figure [6](#F6){ref-type="fig"}).

###### 

Changes in microvascular variables as mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine

                                     **Mean arterial blood pressure**   **ANOVA**   **Linear trend**          
  ---------------------------------- ---------------------------------- ----------- ------------------ ------ ------
  Vascular density (vessels/mm^2^)                                                                            
   Large diameter vessels            11 ± 1                             10 ± 3      10 ± 3             0.81   0.61
   Medium diameter vessels           15 ± 3                             16 ± 4      16 ± 4             0.82   0.53
   Small diameter vessels            24 ± 8                             23 ± 8      22 ± 1             0.09   0.03
  Microvascular flow index                                                                                    
   Large diameter vessels            2.3 ± 0.6                          2.3 ± 0.8   2.2 ± 0.8          0.34   0.16
   Medium diameter vessels           2.2 ± 0.7                          2.2 ± 0.7   2.1 ± 0.9          0.79   0.52
   Small diameter vessels            2.1 ± 0.7                          2.2 ± 0.7   2.0 ± 0.8          0.69   0.47
  Perfused vessels (%)                                                                                        
   Large diameter vessels            82 ± 21                            80 ± 28     87 ± 6             0.46   0.40
   Medium diameter vessels           77 ± 27                            77 ± 29     77 ± 6             0.98   1.00
   Small diameter vessels            72 ± 26                            71 ± 27     67 ± 32            0.55   0.38
   Total vessels                     75 ± 25                            75 ± 27     76 ± 4             0.92   0.73
  Heterogeneity flow index                                                                                    
   Large diameter vessels            1.0 ± 0.5                          1.3 ± 1.2   1.5 ± 1.4          0.07   0.02
   Medium diameter vessels           1.6 ± 1.6                          1.5 ± 1.4   1.7 ± 1.2          0.86   0.78
   Small diameter vessels            1.8 ± 1.3                          1.8 ± 1.2   1.7 ± 1.1          0.97   0.80

ANOVA = analysis of variance.

![Individual behavior of the sublingual capillary density. Results are shown as the mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine.](cc7922-1){#F1}

![Individual behavior of sublingual capillary microvascular flow index. Results are shown as the mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine.](cc7922-2){#F2}

![Individual behavior of sublingual percentage of perfused capillaries. Results are shown as the mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine.](cc7922-3){#F3}

![Individual behavior of sublingual perfused capillary density. Results are shown as the mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine.](cc7922-4){#F4}

![Individual behaviour of sublingual capillary heterogeneity flow index. Results are shown as the mean arterial pressure was increased from 65 mmHg to 85 mmHg with norepinephrine.](cc7922-5){#F5}

![Relationship between the changes of perfused capillary density, when mean arterial pressure (MAP) was increased from the baseline to a MAP of 85 mmHg, with the basal perfused capillary density at a MAP of 65 mmHg.](cc7922-6){#F6}

Discussion
==========

The main finding of this study is that the increase in MAP with norepinephrine failed to improve sublingual microcirculation, or any other variable related to perfusion as arterial lactate, anion gap, ΔPCO~2~, and parameters of oxygen metabolism. Despite a trend to decreased total and perfused capillary density, there were considerable variations in the interindividual responses that seem to depend on the basal condition of the microcirculation.

The goal of vasopressor therapy is to improve tissue perfusion pressure, while avoiding excessive vasoconstriction. Marik and Mohedin showed that an infusion of norepinephrine titrated to increase the MAP to more than 75 mmHg improved intramucosal pH \[[@B26]\]. Martin and colleagues \[[@B27]\] and Desjars and colleagues \[[@B28]\] reported significant increases in urine output and improvements in renal function in septic shock. Nevertheless, in these studies \[[@B26]-[@B28]\] the initial MAP was below 60 mmHg, a value that is most likely beyond the lower limit of autoregulation. On the other hand, Deruddre and colleagues showed that increasing MAP from 65 to 75 mmHg with norepinephrine in patients with septic shock increased urinary output and decreased renal vascular resistance \[[@B29]\].

Our study is consistent with the results from LeDoux and colleagues \[[@B11]\] and Bourgoin and colleagues \[[@B12]\]. In these studies, the lack of change in any perfusion variable over a range of 20 mmHg in MAP suggests that the patients were within their autoregulatory range. Jhanji and colleagues have recently demonstrated that increasing doses of norepinephrine resulted in an increase in global DO~2~, and in cutaneous microvascular flow and tissue partial pressure of oxygen (PO~2~) without significant changes in sublingual microcirculation \[[@B18]\]. They also showed, however, that when MAP was augmented from 70 to 90 mmHg, the MFI, proportion of perfused vessels, and perfused vessel density fell by about 10%. The remarkable similarity between the study by Jhanji and colleagues \[[@B18]\] and the current study emphasizes the reproducibility of the techniques and results.

In addition, our results expand previous knowledge by addressing the variation of interindividual responses. In particular, the change in the perfused capillary density was strongly dependent on the basal state of microcirculation. In this way, perfused capillary density improved in patients with an altered sublingual perfusion at baseline, and decreased in patients with preserved basal microvascular perfusion. Sakr and colleagues described a similar microvascular response to red blood cell transfusion \[[@B30]\]. Other studies have also shown that vasopressors could decrease sublingual microcirculation \[[@B31],[@B32]\], suggesting that excessive vasoconstriction might be deleterious to microcirculation.

Our study has several limitations. First, this observational study lacks a control group. Each patient, therefore, served as his/her own control. Second, the number of patients included in this study was small. Despite the sample size, significant changes in hemodynamic variables developed. Conversely, most parameters related to tissue perfusion and oxygenation remained unchanged or had a trend to worsen. Third, the infusion period was short. A longer period might have allowed the appearance of changes not observed in the present study. Nevertheless, most norepinephrine effects on hemodynamics and on tissue perfusion and oxygenation are expected to be evident within a few minutes. In addition, the short half-life of norepinephrine allows a new steady state to be reached in its plasmatic levels a few minutes after a change in the infusion rate \[[@B33]\]. In fact, several hemodynamic changes appeared shortly after each dose modification. Moreover, the infusion period was deliberately kept short, to avoid the background effects of changes in the underlying conditions of the patients. With longer periods of evaluation, a time effect with spontaneous changes of the studied variables related to the natural history of the disease might not be ruled out. Finally, as a different behaviour of microcirculatory beds is a characteristic of sepsis \[[@B3],[@B34]\], this study does not address the response of other territories to increasing MAP.

Conclusions
===========

In this observational study, patients with septic shock showed severe microcirculatory alterations that failed to improve with the increases in MAP with norepinephrine. Furthermore, linear trend analysis showed reductions in the capillary and in the perfused capillary densities. Nevertheless, interindividual responses could be quite variable and dependent on the basal state of the microcirculation. Our results suggest that the increase in MAP above 65 mmHg is not a straightforward treatment to improve microvascular perfusion. It might be harmful for some patients, while benefiting others. Studies including greater numbers of patients are needed to determine the usefulness of individual titration of vasopressor therapy on sublingual microcirculation.

Key messages
============

• Patients with septic shock showed severe microcirculatory abnormalities that an increase in MAP with norepinephrine globally failed to improve.

• The change in the perfused capillary density was strongly dependent on the basal state of the microcirculation. Thus, perfused capillary density improved in patients with an altered sublingual perfusion at baseline, and decreased in patients with preserved basal microvascular perfusion.
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